Enact Holdings, Inc. (ACT): what the price assumes

In the published model solve dated 2026-Q2, anchored at $49.07, Enact Holdings, Inc. (ACT) is priced for 9.9% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Exported: 2026-08-31 · Source: https://boothcheck.com/report/ACT

Headline

FieldValue
TickerACT
CompanyEnact Holdings, Inc.
Sector / IndustryFinancial Services
Current price$49.07/sh

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfinancials
Return on equity needed9.9%
Return on equity now12.6%
ROE gap-2.7pp
Price-to-book1.25x

Solve inputs: computed at a 8.7% cost of equity with 4% terminal growth over a 10-year stage, on common book equity (FY2026).

How unusual the bet is: within-range

ReferenceValue
vs own history-2.09σ
cohort percentile (of 78 peers)30
sustained it ~10 years at this level76%
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and earnings-power and relative-multiple value. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0.79x3justifies
Earnings0.71x2justifies
Relative0.86x3justifies
Growth1.42x1expensive

Families that justify the price: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.5%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowthno
Bank Fair Value (P/TBV)$70.770.69xyesTBVPS $39.24 × 1.80x (ROE (TTM) 12.7% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption))
Relative ValuationRelative$55.990.88xyesP/E 11x (static sector reference · 2026-04), scenarios: 9.2x / 11.0x / 12.8x (bear / base = reference held flat / bull), EV/EBITDA 10x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$53.730.91xyesBV/sh $39.24, ROE (TTM) 12.7%, ke 9.3%
Two-Stage Excess ReturnAsset$62.390.79xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$34.501.42xyesRev $1.3B, growth 3% (input: historical growth; tapered), Terminal P/S: 4.5x / 5.4x / 6.2x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$57.120.86xyesEPS $4.76, growth 9% (input: historical EPS growth), PEG=1.14 (Fair)
Margin TrajectoryGrowthno
Earnings Power ValueEarningsno
Residual IncomeAssetno
Graham NumberAsset$64.830.76xyes√(22.5 × EPS $4.76 × BVPS $39.24) — Graham's conservative floor
EV/EBITDA RelativeRelativeno
FCF YieldEarningsno
SBC-Adj FCF YieldEarningsno
Ben Graham FormulaEarnings$103.060.48xyesEPS $4.76 × (8.5 + 2×8.7%) × (4.4 / 5.3%)
ROIC-Justified P/BAssetno
P/Sales SectorRelativeno
PEG Fair ValueRelative$61.880.79xyesEPS $4.76 × (PEG 1.5 × growth 8.7% (input: historical EPS growth)) → PE 13.0x
Earnings YieldEarnings$51.460.95xyesEPS $4.76 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

The issuer is a capital-light fee financial or exchange/data business rather than a funded risk book. Enterprise and cash-flow methods remain coherent; bank P/TBV and policyholder-float treatment do not apply.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Mortgage Insuranceoperatingenterprise1.2B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Share count CAGR (buyback)-3.7%

Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).

Bullet Takeaways

Bull Case

The capital position is where this story starts, because in mortgage insurance capital is not a cushion, it is the licence. Enact operates under the eligibility rules the two housing agencies set, which require that its most liquid assets exceed a minimum determined by the risk it carries. The company keeps that requirement comfortably met while also running a reinsurance programme against it, and the filing explains what the programme buys: "our CRT program helps to manage risk in our operating model and spread the risk of loss across our counterparties while also providing capital relief". As of the end of 2025 that third-party reinsurance produced a credit of $1,932 million against the required amount, up from $1,885 million a year earlier. The revolving credit facility sat undrawn.

What that structure allows is a distribution policy most financial companies cannot support. Roughly 74.6% of the last fiscal year's earnings went back to shareholders as dividends plus buybacks, and the share count has fallen about 3.3% a year over the four years to March 2026. Management raised the quarterly dividend 14% to $0.24 a share in May 2026. A regulated insurer only pays out at that rate when the regulator, the agencies and the board all agree the capital underneath is surplus to requirement. The payout is a statement about the balance sheet, made by people with access to the loan-level data.

The return that capital earns is the second point. Enact has recently been earning a return on equity of about 12.6%, against a cost of equity just under nine percent. An insurer creating that spread on its book is worth more than the book itself, and the market pays about 1.2 times it, roughly $46.73 against $37.46 of book per share. The gap between what the business earns and what the capital costs is the entire economic engine, and it has been running above its cost for long enough to look structural rather than cyclical.

The risk taken to earn it is narrower than the loan balances imply. Coverage runs "typically between 6% and 35% coverage" per policy, so the insurer's exposure is a defined top layer rather than the mortgage itself. Loss mitigation is active rather than passive: "When we receive notice of a delinquency, we use our proprietary model to determine whether a delinquent loan is a candidate for a modification." A delinquency is not a claim, and a large share of delinquencies cure. That distinction is why an insurer with a book written into high home prices can carry an elevated delinquency count without a corresponding loss.

The industry structure helps too. Four peers make up most of the private market alongside Enact, none of them dominant, and all of them writing against the same agency rulebook. Among that group Radian carries $1.37 billion of revenue and Essent $1.28 billion, against Enact's smaller base, but the profitability of the cohort is uniformly high because the product is priced off a risk that has been benign. New business is also being pre-hedged: the company entered an excess-of-loss reinsurance transaction on October 27, 2025 covering part of the insurance it expects to write from January 1, 2027 onward. Committing reinsurance capacity that far ahead is a company managing the next cycle rather than the next quarter.

Bear Case

Here is the part that sits uncomfortably with the reported numbers. A mortgage insurer does not set aside money for the losses it expects on the loans it has already insured. Reserves attach only when a loan goes bad, and the filing is explicit that the trigger is "loans that servicers have reported to us as being in default, which is typically after the second missed payment", supplemented by "incurred but not reported ("IBNR") reserves for estimated losses incurred on loans in default that have not yet been reported to us by servicers". So a book of insurance written into rising home prices produces almost no reserve charge while conditions hold, and the reported return on equity of about 12.6% reflects that. The earnings are real. They are also the earnings of a business whose cost of goods sold has not yet arrived.

The company itself flags how sensitive the number is: "Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition." That is not boilerplate. In this industry the difference between a good year and a bad one is a modelling assumption about how many delinquent borrowers cure, and that assumption is calibrated on a period in which borrowers had substantial equity to protect.

The price reflects some of this already, and that is the awkward part of the bear case. At $46.73 the market assumes the company sustains a return on equity of about 9.9%, well below the roughly 12.6% it has been earning, and roughly three-quarters of firms earning a return like this have held it for as long as a decade. The value-oriented approaches all land above the price. So the bear thesis is not that the shares are expensive; it is that the assumption being discounted, a return drifting down toward the cost of capital, is the mild version of what a housing downturn does. Mortgage insurance results do not fade gently. They compound in one direction for years and then reprice in two quarters.

Pricing power is limited in exactly the wrong way. The filing states the competitive position plainly: "The U.S. private mortgage insurance industry is highly competitive." and, on the ability to respond to worsening risk, "We may be unable to increase premium rates for various reasons, principally due to competition." An insurer that cannot raise price when risk rises has one lever left, which is writing less business, and that shrinks the earning asset. Customer concentration sharpens it further, since the filing names "customer concentration levels with certain customers that actively market refinancing opportunities to their existing borrowers" as a factor that runs off insurance in force.

Two other dependencies sit outside management's control. The agencies set the eligibility rules and hold approval rights over the business: "compliance with PMIERs requires us to seek the GSEs' prior approval before taking many actions". And the parent relationship is a live channel for reputational risk, with the company noting that "our relationships with our customers may be adversely affected by the ratings assigned to Genworth or its other operating subsidiaries". A shareholder here owns a well-capitalised insurer whose licence, product design and customer perception all depend on parties whose incentives are not identical to their own.

Valuation

An insurer is worth the return it earns on the capital it holds, so the arithmetic here runs off book value rather than an earnings multiple. At $46.73 on July 25, 2026, the shares carry about 1.2 times the equity behind them. Read backwards, that says the market assumes Enact sustains a return on equity of about 9.9%. The business has recently been earning a return on equity of about 12.6%. What is embedded, then, is a fade of roughly three percentage points in profitability and no more: a mild assumption rather than a heroic one, and not a bargain-basement one either.

Persistence is what makes that assumption reasonable or not. Returns at this level are not rare in this industry and they are not fragile in the ordinary sense: roughly three-quarters of companies earning a comparable return have held it for as long as a decade. Against Enact's own record the assumed return is comfortably inside what the business has delivered. And against the other listed mortgage insurers, this multiple of book sits in the cheaper half of the group rather than the expensive half.

The static approaches agree with each other, which is unusual and worth saying plainly. Book value plus the excess return on it, the conservative earnings-based screens, and the peer-ratio comparisons all land above today's price. Only one lens lands below, and it is a revenue-multiple projection that carries today's price-to-sales ratio forward, which is a poor instrument for an insurer whose revenue line mixes premiums with investment income and whose value comes from underwriting spread rather than sales growth. Discount that one and every remaining approach reads the shares as supported.

The peer group provides the scale context rather than a verdict. Radian generated $1.37 billion of revenue over the trailing year with growth of 14.1%; Essent $1.28 billion; MGIC $1.20 billion with revenue down 1.2%; NMI Holdings $717 million with growth of 7.3%. Enact sits inside that band. Profitability across the whole cohort runs above half of revenue, which tells you the industry is currently earning very well and says nothing about whether it will continue to.

Capital and payout are the right closing frame for a company like this, not leverage or coverage ratios. About 74.6% of the last fiscal year's earnings were returned as dividends plus buybacks, the share count has fallen roughly 3.3% a year over the four years to March 2026, and the reinsurance programme carries a credit of $1,932 million against the required capital, which is what allows the distribution to be that large. One sensitivity is worth naming: a single extra percentage point on the cost of equity raises the return the price demands by roughly 1.2 points. Since the cost of equity for a housing-cycle business moves with credit spreads, the same event that damages the underwriting also raises the bar the shares are judged against.

Catalysts

The dividend increase in the spring is the clearest recent signal about how management reads its own capital. The board declared a quarterly dividend of $0.24 per common share in May 2026, a 14% increase from the prior quarter, payable on June 18, 2026 to holders of record on May 28, 2026. First-quarter 2026 results, released after the close on May 5, 2026, showed revenue of $312.07 million and net income of $167.77 million, with diluted earnings per share from continuing operations of $1.18. Buyback activity was increased alongside the dividend.

One forward commitment already sits on the books. On October 27, 2025 the company entered an excess-of-loss reinsurance transaction covering a portion of the insurance it expects to write from January 1, 2027 onward. That is capacity secured well before the risk is underwritten, and it matters because reinsurance pricing tightens exactly when housing conditions deteriorate. A company that has already bought its protection for the following year has removed one variable from its own cost base.

The next dated checkpoint is close. Enact releases second-quarter 2026 results after the market closes on August 5, 2026, with the conference call the following morning. Two lines in that release carry the information: the delinquency count and how many of those delinquencies are curing, which is the leading indicator for everything else in the model, and the pace of share repurchase, which reveals whether management still regards its capital as surplus.

Peer Cohorts (Per Segment, With Filing Citations)

Mortgage Insurance (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Enact press release, July 2026 · Enact press release, May 2026 · Enact first quarter 2026 results, May 2026

View the full interactive ACT report on boothcheck